Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New 1,2,4-triazole-Chalcone hybrids induce Caspase-3 dependent apoptosis in A549 human lung adenocarcinoma cells
Fatma F. Ahmed, Amer Ali Abd El‐Hafeez, Samar H. Abbas, et al.
European Journal of Medicinal Chemistry (2018) Vol. 151, pp. 705-722
Closed Access | Times Cited: 76

Showing 1-25 of 76 citing articles:

The caspase-3/GSDME signal pathway as a switch between apoptosis and pyroptosis in cancer
Mingxia Jiang, Ling Qi, Lisha Li, et al.
Cell Death Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 442
Apoptosis, Pyroptosis, and Necroptosis—Oh My! The Many Ways a Cell Can Die
Natália Ketelut-Carneiro, Katherine A. Fitzgerald
Journal of Molecular Biology (2021) Vol. 434, Iss. 4, pp. 167378-167378
Closed Access | Times Cited: 256
Chalcone Derivatives: Role in Anticancer Therapy
Yang Ouyang, Juanjuan Li, Xinyue Chen, et al.
Biomolecules (2021) Vol. 11, Iss. 6, pp. 894-894
Open Access | Times Cited: 239
Anticancer Activity of Natural and Synthetic Chalcones
Teodora Constantinescu, Claudiu N. Lungu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11306-11306
Open Access | Times Cited: 114
EGFR inhibitors and apoptotic inducers: Design, synthesis, anticancer activity and docking studies of novel xanthine derivatives carrying chalcone moiety as hybrid molecules
Hesham A. Abou‐Zied, Bahaa G. M. Youssif, Mamdouh F. A. Mohamed, et al.
Bioorganic Chemistry (2019) Vol. 89, pp. 102997-102997
Closed Access | Times Cited: 116
Chalcone hybrids as potential anticancer agents: Current development, mechanism of action, and structure‐activity relationship
Feng Gao, Gang Huang, Jiaqi Xiao
Medicinal Research Reviews (2020) Vol. 40, Iss. 5, pp. 2049-2084
Closed Access | Times Cited: 104
Design and synthesis of novel quinoline/chalcone/1,2,4-triazole hybrids as potent antiproliferative agent targeting EGFR and BRAFV600E kinases
Aliaa M. Mohassab, Heba A. Hassan, Dalia Abdelhamid, et al.
Bioorganic Chemistry (2020) Vol. 106, pp. 104510-104510
Closed Access | Times Cited: 85
New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization
Hamada H. H. Mohammed, Amer Ali Abd El‐Hafeez, Kareem Ebeid, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1346-1363
Open Access | Times Cited: 37
Structural modification strategies of triazoles in anticancer drug development
Qianwen Guan, Ziming Gao, Yuting Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116578-116578
Closed Access | Times Cited: 8
Pyrazole-thiazole hybrids: Synthesis, computational studies and impact on digestive enzymes
Sidhant Yadav, Raman Lakhia, Anjaneyulu Bendi, et al.
Journal of Molecular Structure (2024) Vol. 1316, pp. 138847-138847
Closed Access | Times Cited: 7
Synthesis and biological evaluation of novel xanthine derivatives as potential apoptotic antitumor agents
Mohamed Hisham, Bahaa G. M. Youssif, Essam Eldin A. Osman, et al.
European Journal of Medicinal Chemistry (2019) Vol. 176, pp. 117-128
Closed Access | Times Cited: 73
Recent advances in α,β-unsaturated carbonyl compounds as mitochondrial toxins
Mohammad Hossain, Umashankar Das, Jonathan R. Dimmock
European Journal of Medicinal Chemistry (2019) Vol. 183, pp. 111687-111687
Closed Access | Times Cited: 63
Exploring recent developments on 1,2,4‐triazole: Synthesis and biological applications
Reshma Sathyanarayana, Boja Poojary
Journal of the Chinese Chemical Society (2020) Vol. 67, Iss. 4, pp. 459-477
Closed Access | Times Cited: 61
Design, synthesis, cytotoxic activities, and molecular docking of chalcone hybrids bearing 8-hydroxyquinoline moiety with dual tubulin/EGFR kinase inhibition
Mohammed M. Amin, Gamal El‐Din A. Abuo‐Rahma, Montaser Sh. A. Shaykoon, et al.
Bioorganic Chemistry (2023) Vol. 134, pp. 106444-106444
Closed Access | Times Cited: 15
Design, synthesis and in silico molecular docking evaluation of novel 1,2,3-triazole derivatives as potent antimicrobial agents
Sudhakar Reddy Baddam, Mahesh Kumar Avula, Raghunadh Akula, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e27773-e27773
Open Access | Times Cited: 6
In Silico Study of Bioactive Compounds Fucoxanthin and Fucoidan from Sargassum echinocarpum as Anti-Cancer Agents Targeting Caspase-3 Protein
Lulus Mualimin, Mentari Sekar Arum
Aquatic Life Sciences. (2025) Vol. 1, Iss. 2, pp. 45-52
Open Access
Therapeutic potential of chalcone-1,2,3-triazole hybrids as anti-tumour agents: a systematic review and SAR studies
Sakshi Priya, Md. Shafiqul Islam, Shivani Kasana, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 4, pp. 449-465
Closed Access
New antiproliferative 1,3,4-oxadiazole/benzimidazole derivatives: Design, synthesis, and biological evaluation as dual EGFR and BRAFV600E inhibitors
Fatma Fouad Hagar, Samar H. Abbas, Ahmed M. Sayed, et al.
Bioorganic Chemistry (2025) Vol. 157, pp. 108297-108297
Closed Access
1,3,4-oxadiazole/chalcone hybrids: Design, synthesis, and inhibition of leukemia cell growth and EGFR, Src, IL-6 and STAT3 activities
Marwa Ali A. Fathi, Amer Ali Abd El‐Hafeez, Dalia Abdelhamid, et al.
Bioorganic Chemistry (2018) Vol. 84, pp. 150-163
Open Access | Times Cited: 56
The preventive effect of phenolic-rich extracts from Chinese sumac fruits against nonalcoholic fatty liver disease in rats induced by a high-fat diet
Zihuan Wu, Yan Zhang, Xiarong Gong, et al.
Food & Function (2019) Vol. 11, Iss. 1, pp. 799-812
Closed Access | Times Cited: 42
Recent Development of 1,2,4-triazole-containing Compounds as Anticancer Agents
Xiaoyue Wen, Yong-qin Zhou, Junhao Zeng, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 16, pp. 1441-1460
Closed Access | Times Cited: 41
Development of triazolothiadiazine derivatives as highly potent tubulin polymerization inhibitors: Structure-activity relationship, in vitro and in vivo study
Weifeng Ma, Peng Chen, Xian‐Sen Huo, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112847-112847
Closed Access | Times Cited: 41
Exploring the Synergistic Anticancer Potential of Benzofuran–Oxadiazoles and Triazoles: Improved Ultrasound- and Microwave-Assisted Synthesis, Molecular Docking, Hemolytic, Thrombolytic and Anticancer Evaluation of Furan-Based Molecules
Ali Irfan, Sadia Faiz, Azhar Rasul, et al.
Molecules (2022) Vol. 27, Iss. 3, pp. 1023-1023
Open Access | Times Cited: 23
Thienopyrimidine–Chalcone Hybrid Molecules Inhibit Fas-Activated Serine/Threonine Kinase: An Approach To Ameliorate Antiproliferation in Human Breast Cancer Cells
Nashrah Sharif Khan, Parvez Κhan, Mohammad Fawad Ansari, et al.
Molecular Pharmaceutics (2018) Vol. 15, Iss. 9, pp. 4173-4189
Closed Access | Times Cited: 41
Leukemia therapy by flavonoids: Future and involved mechanisms
Raedeh Saraei, Faroogh Marofi, Adel Naimi, et al.
Journal of Cellular Physiology (2018) Vol. 234, Iss. 6, pp. 8203-8220
Closed Access | Times Cited: 40
Page 1 - Next Page

Scroll to top